Literature DB >> 6865271

[Does long term treatment with high dose nitrates affect prognosis in coronary heart disease?].

W D Bussmann, B Giebeler.   

Abstract

The daily dose of nitrates was determined in 293 patients who had undergone coronary angiography seven years earlier. A questionnaire was filled out by those still living; medical records and information provided by family physicians were used for those who had died during the intervening period. The dose could be ascertained in a total of 168 patients. Patients were divided into two groups: in group I were those with a daily isosorbide dinitrate dose of less than 40 mg (n = 46), in group II those with a dose greater than 40 mg (n = 72). 56 patients had died. Two-thirds of them had been on the low-dose regimen, whereas only one-third were in the high-dose group. The extent of ventricular impairment was comparable in both groups. Seven-year mortality in group I was 39% with a mean daily nitrate dose of 14 mg. In group II, however, only 26% died with a mean daily dose of 55 mg. The difference can already be seen during the first year. Age, extent of coronary sclerosis, degree of ventricular damage, and cardiac size were identical in both groups. Thus mortality rate in group II was reduced by 30-40%. A causal relation to the height of the nitrate dose should be considered.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6865271     DOI: 10.1007/bf01488157

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  15 in total

1.  Favorable effects of prolonged nitroglycerin infusion in patients with acute myocardial infarction.

Authors:  J P Derrida; R Sal; P Chiche
Journal:  Am Heart J       Date:  1978-12       Impact factor: 4.749

2.  Effects of vasodilator therapy for severe pump failure in acute myocardial infarction on short-term and late prognosis.

Authors:  K Chatterjee; H J Swan; V S Kaushik; G Jobin; P Magnusson; J S Forrester
Journal:  Circulation       Date:  1976-05       Impact factor: 29.690

3.  Improvement in prognosis of myocardial infarction by long-term beta-adrenoreceptor blockade using practolol. A multicentre international study.

Authors: 
Journal:  Br Med J       Date:  1975-09-27

4.  Improvement in prognosis of myocardial infarction by long-term beta-adrenoceptor blockade.

Authors:  K G Green; D A Chamberlain; R M Fulton; N A Hamer; M F Oliver; B L Pentecost
Journal:  Am Heart J       Date:  1976-10       Impact factor: 4.749

5.  [The effect of nitroglycerin on ventricular extrasystoles in acute myocardial infarction (author's transl)].

Authors:  W D Bussmann; K Neumann; M Kaltenbach
Journal:  Dtsch Med Wochenschr       Date:  1980-03-14       Impact factor: 0.628

6.  [Nitroglycerin in myocardial infarct. From contraindication to indication].

Authors:  W D Bussmann
Journal:  Dtsch Med Wochenschr       Date:  1980-11-07       Impact factor: 0.628

7.  Multicentre post-infarction trial of propranolol in 49 hospitals in the United Kingdom, Italy, and Yugoslavia.

Authors:  N S Baber; D W Evans; G Howitt; M Thomas; T Wilson; J A Lewis; P M Dawes; K Handler; R Tuson
Journal:  Br Heart J       Date:  1980-07

8.  Effect of propranolol in myocardial infarction.

Authors:  P J Snow
Journal:  Lancet       Date:  1965-09-18       Impact factor: 79.321

9.  [Possible evidence for a reduction of early and late mortality during nitroglycerin therapy in acute myocardial infarction].

Authors:  W D Bussmann; M Haller
Journal:  Klin Wochenschr       Date:  1983-04-15

10.  [Reduction of CK and CK-MB enzyme levels as indicators of infarct size by intravenous nitroglycerin (author's transl)].

Authors:  W D Bussmann; D Passek; W Seidel; H Klepzig; M Kaltenbach
Journal:  Z Kardiol       Date:  1980-01
View more
  1 in total

Review 1.  Nitrates: why and how should they be used today? Current status of the clinical usefulness of nitroglycerin, isosorbide dinitrate and isosorbide-5-mononitrate.

Authors:  S Silber
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.